Jonathan N King

7PUBLICATIONS
9CO-AUTHORS
Biologically active moleculesTraditional Chinese medicine and treatmentsAnimal developmental and reproductive biologyCardiology (incl. cardiovascular diseases)Animal welfare
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 23, 2022
Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.

Peter Lees, Pierre-Louis Toutain, Jonathan Elliott

|Jul 01, 2021
Clinical safety of robenacoxib in cats with chronic musculoskeletal disease.

Jonathan N King, Wolfgang Seewald, Sophie Forster

|Apr 21, 2021
Determination of the route of excretion of robenacoxib (Onsior™) in cats and dogs: A pilot study.

Jonathan N King, Martin Jung

|Sep 28, 2019
Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial.

Jonathan N King, Mike Martin, Valérie Chetboul

|Feb 03, 2018
Effect of benazepril and pimobendan on serum angiotensin-converting enzyme activity in dogs.

J N King, C Christinaz, G Strehlau

|Jul 03, 2017
Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical Trial.

J N King, A Font, J-F Rousselot

Pageof 2

Frequent Collaborators

1 joint publications

Valérie Chetboul

1 joint publications

Sophie Forster

1 joint publications

Gabriele Friton

1 joint publications

Derek E Adrian